• English
    • français
  • Help
  •  | 
  • Contact
  •  | 
  • About
  •  | 
  • Login
  • HAL portal
  •  | 
  • Pages Pro
  • EN
  •  / 
  • FR
View Item 
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
  •   LillOA Home
  • Liste des unités
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Cyclophosphamide versus Etoposide in ...
  • BibTeX
  • CSV
  • Excel
  • RIS

Document type :
Article dans une revue scientifique
DOI :
10.1002/ajh.25091
PMID :
29574915
Permalink :
http://hdl.handle.net/20.500.12210/4643
Title :
Cyclophosphamide versus Etoposide in Combination with Total Body Irradiation as Conditioning Regimen for Adult Patients with Ph-negative Acute Lymphoblastic Leukemia Undergoing Allogeneic Stem Cell Transplant: On behalf of the ALWP of the EBMT.
Author(s) :
Czyz, Anna [Auteur]
Labopin, Myriam [Auteur]
Giebel, Sebastian [Auteur]
Socie, Gerard [Auteur]
Apperley, Jane [Auteur]
Volin, Liisa [Auteur]
Remenyi, Peter [Auteur]
Yakoub-Agha, Ibrahim [Auteur] refId
Lille Inflammation Research International Center - U 995 [LIRIC]
Orchard, Kim [Auteur]
Michallet, Mauricette [Auteur]
Stuhler, Gernot [Auteur]
Chaganti, Sridhar [Auteur]
Murray, Martin [Auteur]
Aljurf, Mahmoud [Auteur]
Bloor, Adrian [Auteur]
Passweg, Jakob [Auteur]
Finke, Jurgen [Auteur]
Mohty, Mohamad [Auteur]
Nagler, Arnon [Auteur]
Journal title :
American journal of hematology
Abbreviated title :
Am. J. Hematol.
Publication date :
2018-03-25
ISSN :
1096-8652
HAL domain(s) :
Sciences du Vivant [q-bio]
English abstract : [en]
Allogeneic hematopoietic cell transplantation (alloHCT) with myeloablative conditioning based on total body irradiation (TBI) is widely used for the treatment of adults with acute lymphoblastic leukemia (ALL). TBI is ...
Show more >
Allogeneic hematopoietic cell transplantation (alloHCT) with myeloablative conditioning based on total body irradiation (TBI) is widely used for the treatment of adults with acute lymphoblastic leukemia (ALL). TBI is most frequently administered in combination with either cyclophosphamide (Cy/TBI) or etoposide (Vp/TBI). The goal of this study was to retrospectively compare these two regimens. Adult patients with Ph-negative ALL treated with alloHCT in first or second complete remission who received Cy/TBI (n = 1346) or Vp/TBI (n = 152) conditioning were included in the analysis. In a univariate analysis, as compared to Cy/TBI, the use of Vp/TBI was associated with reduced incidence of relapse (17% vs. 30% at 5 years, P = .007), increased rate of leukemia-free survival (60% vs. 50%, P = .04), and improvedShow less >
Language :
Anglais
Audience :
Internationale
Popular science :
Non
Administrative institution(s) :
Inserm
Université de Lille
CHU Lille
Collections :
  • Institut de Recherche Translationnelle sur l'Inflammation (INFINITE) - U1286
Research team(s) :
Immunity, inflammation and fibrsis in auto and allo-reactivity
Submission date :
2019-03-01T14:17:55Z
Université de Lille

Mentions légales
Université de Lille © 2017